Discover
BEAT
HeartBeam, Inc.
0.48
2 x 0.30
1 x 0.63
bid
ask
-
0.01
1.74%
2 @ 07:58 PM
0.47 -0.01 (2.48%)
| Ytd | -79.99% | |
| 1y | -72.87% |
0.47
day range
0.51
0.36
52 week range
3.44
| Open | 0.49 | Prev Close | 0.49 | Low | 0.47 | High | 0.51 | Mkt Cap | 27.06M |
| Vol | 1.51M | Avg Vol | 7.37M | EPS | -0.49 | P/E | N/A | Forward P/E | -4.51 |
| Beta | -0.99 | Short Ratio | 1.64 | Inst. Own | 8.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.47 | 200-d Avg | 1.03 | 1yr Est | 5.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-07 | 2024-09 | 0 | -0.19 | N/A | N/A |
| 2024-08-14 | 2024-06 | 0 | -0.19 | N/A | N/A |
| 2024-05-09 | 2024-03 | 0 | -0.17 | N/A | N/A |
| 2024-03-20 | 2023-12 | -0.12 | -0.13 | -0.01 | -8.33% |
| 2023-11-14 | 2023-09 | -0.12 | -0.13 | -0.01 | -8.33% |
| 2023-08-10 | 2023-06 | -0.1 | -0.16 | -0.06 | -60.00% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-11-15 | Benchmark | Upgrade | Speculative Buy | Speculative Buy |
| 2024-05-13 | Benchmark | Upgrade | Speculative Buy | Speculative Buy |
| 2024-03-25 | Benchmark | Upgrade | Speculative Buy | Speculative Buy |
| 2023-11-16 | Benchmark | Upgrade | Speculative Buy | Speculative Buy |
| 2023-08-24 | Benchmark | Upgrade | Speculative Buy | Speculative Buy |
| 2023-05-19 | Alliance Global Partners | Upgrade | Buy | Buy |
Profile
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-02-09 | BROUNSTEIN RICHARD D | Chief Financial Officer | 112.11K | Conversion of Exercise of derivative security |
| 2024-09-05 | DE URIOSTE GEORGE A. | Director | 57.15K | Sale |
| 2024-06-11 | ELFRINK WILLHEM P. | Director | 424.81K | Stock Award(Grant) |
| 2024-06-11 | FERRARI RICHARD M | Director | 215.38K | Stock Award(Grant) |
| 2024-06-11 | JAFF MICHAEL R. | Director | 75.12K | Stock Award(Grant) |
| 2024-06-11 | NELSON KENNETH WARWICK III | Director | 127.15K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Group Inc | 750.71K | 1.79M | 2.82% |
| 2024-09-29 | Smith Salley Wealth Management | 250.00K | 597.50K | 0.94% |
| 2024-09-29 | Geode Capital Management, LLC | 233.40K | 557.82K | 0.88% |
| 2024-09-29 | UBS Group AG | 160.00K | 382.40K | 0.60% |
| 2024-09-29 | Ritholtz Wealth Management | 139.18K | 332.64K | 0.52% |
| 2024-09-29 | O'Shaughnessy Asset Management LLC | 139.18K | 332.64K | 0.52% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 537.09K | 1.28M | 2.01% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 200.32K | 478.76K | 0.75% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 126.14K | 301.46K | 0.47% |
| 2024-10-30 | iShares Micro Cap ETF | 46.46K | 111.03K | 0.17% |
| 2024-10-30 | Fidelity Total Market Index Fund | 38.60K | 92.25K | 0.14% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 30.07K | 71.87K | 0.11% |